Cite
HARVARD Citation
Cai, F. et al. (2020). Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway. Bioscience reports. 40 (3), p. . [Online].